Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways-Reference-Cited by-同舟云学术

Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways

Published:2021-05 Issue:5 Volume:2 Page:100262
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Herati Ramin Sedaghat,Silva Luisa Victoria,Vella Laura A.,Muselman Alexander,Alanio Cecile,Bengsch Bertram,Kurupati Raj K.,Kannan Senthil,Manne Sasikanth,Kossenkov Andrew V.,Canaday David H.,Doyle Susan A.,Ertl Hildegund C.J.,Schmader Kenneth E.,Wherry E. John

Funder

NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference83 articles.

1. Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence;Lang;Clin. Interv. Aging,2012

2. Understanding immunosenescence to improve responses to vaccines;Goronzy;Nat. Immunol.,2013

3. T follicular helper cell development and functionality in immune ageing;Gustafson;Clin. Sci. (Lond.),2018

4. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals;Henry;Cell Host Microbe,2019

5. Markers of T Cell Senescence in Humans;Xu;Int. J. Mol. Sci.,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefit delayed immunosenescence by regulating CD4⁺T cells: A promising therapeutic target for aging‐related diseases;Aging Cell;2024-08-18

2. SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses;Frontiers in Immunology;2024-06-06

3. Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision;Journal for ImmunoTherapy of Cancer;2024-06

4. TIGIT+Tfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre;Frontiers in Immunology;2024-05-29

5. Opportunities and challenges for T cell-based influenza vaccines;Nature Reviews Immunology;2024-05-02